Adult Cholangiocarcinoma — Trials

Adult Cholangiocarcinoma — Trials · CancerIndex

Clinical trials

Registered studies

9 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 1
Recruiting: 0
Ph III recruiting: 0
Growth YoY: —
Industry share: 100%
Top sponsor: 3D Medicines (Beijing) Co., Ltd.
Termination share: —

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (3)

clinicaltrialsPublishedShowing 1–1 of 1 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT05039892	Efficacy and Safety of 3D185 Monotherapy in Subjects With Previously Treated Locally Advanced or Metastatic Cholangiocarcinoma	not yet recruiting	Phase 2	50	3D Medicines (Beijing) Co., Ltd.INDUSTRY	0	Sep 9, 2026	clinicaltrials

Data updated 21 days agoSource updated Sep 9, 2026source: clinicaltrials